• SpyBiotech Licenses Selexis’ SUREtechnology for HCMV Vax contractpharma
    March 19, 2021
    Selexis SA, a JSR Life Sciences company, and SpyBiotech, a biotechnology company with a novel vaccine platform, have signed a commercial license agreement to advance SPYVLP102, SpyBiotech’s lead vaccine program for human cytomegalovirus (HCMV).
  • 3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement contractpharma
    October 28, 2020
    ​3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement with SpyBiotech, a company with a novel vaccine platform to..
PharmaSources Customer Service